These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10976608)

  • 21. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors.
    Hagan H; McGough JP; Thiede H; Hopkins S; Duchin J; Alexander ER
    J Subst Abuse Treat; 2000 Oct; 19(3):247-52. PubMed ID: 11027894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.
    Leprêtre A; Ba I; Lacombe K; Maynart M; Toufik A; Ndiaye O; Kane CT; Gozlan J; Tine J; Ndoye I; Raguin G; Girard PM
    J Int AIDS Soc; 2015; 18(1):19888. PubMed ID: 26004637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010.
    Yen YF; Rodwell TC; Yen MY; Hsu YH; Chuang P; Li LH; Su LW; Yang YH; Jiang XR; Fang YC; Garfein RS
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):544-50. PubMed ID: 22783806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion.
    Hagan H; Thiede H; Des Jarlais DC
    Epidemiology; 2004 Sep; 15(5):543-9. PubMed ID: 15308953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strong HIV and hepatitis disclosure norms and frequent risk behaviors among Hungarian drug injectors.
    Gyarmathy VA; Neaigus A; Ujhelyi E; Szabó T; Rácz J
    Drug Alcohol Depend; 2006 Apr; 82 Suppl 1(Suppl 1):S65-9. PubMed ID: 16769448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program.
    Millson P; Challacombe L; Villeneuve PJ; Strike CJ; Fischer B; Myers T; Shore R; Hopkins S
    AIDS Educ Prev; 2007 Apr; 19(2):124-36. PubMed ID: 17411415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The changing epidemiology of HIV infection in injecting drug users in Dublin, Ireland.
    Clarke S; Keenan E; Bergin C; Lyons F; Hopkins S; Mulcahy F
    HIV Med; 2001 Oct; 2(4):236-40. PubMed ID: 11737403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus incidence among injecting drug users on opioid replacement therapy.
    Hallinan R; Byrne A; Amin J; Dore GJ
    Aust N Z J Public Health; 2004 Dec; 28(6):576-8. PubMed ID: 15707209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of risky injection practices associated with hepatitis B, hepatitis C, and human immunodeficiency virus and using the blood-borne virus transmission risk assessment questionnaire.
    Reynolds GL; Fisher DG; Napper LE
    J Addict Dis; 2012; 31(1):80-8. PubMed ID: 22356671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995.
    Broers B; Junet C; Bourquin M; Déglon JJ; Perrin L; Hirschel B
    AIDS; 1998 Oct; 12(15):2059-66. PubMed ID: 9814875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
    Vassilev ZP; Hagan H; Lyubenova A; Tomov N; Vasilev G; Krasteva D; Des Jarlais DC
    Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia.
    Uusküla A; McNutt LA; Dehovitz J; Fischer K; Heimer R
    Int J STD AIDS; 2007 Jan; 18(1):41-6. PubMed ID: 17326862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme.
    Chamot E; de Saussure P; Hirschel B; Déglon JJ; Perrin LH
    AIDS; 1992 Apr; 6(4):430-1. PubMed ID: 1616640
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W; Stanley J; Langton D; Kelly Y; Bury G
    Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methadone maintenance and hepatitis C virus infection among injecting drug users.
    Crofts N; Nigro L; Oman K; Stevenson E; Sherman J
    Addiction; 1997 Aug; 92(8):999-1005. PubMed ID: 9376782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.